[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Status and Outlook 2018-2025

August 2018 | 147 pages | ID: G3368D6CCC3EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies
  • Allergan Plc
  • Galapagos NV
  • Merck & Co Inc
  • Syntiron LLC
  • Valevia UK Ltd
Market by Type
  • VAL-301
  • GLPG-1492
  • Solithromycin
  • Acorafloxacin Hydrochloride
  • Others
Market by Application
  • Hospital
  • Clinic
  • Others
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 VAL-301
  3.1.2 GLPG-1492
  3.1.3 Solithromycin
  3.1.4 Acorafloxacin Hydrochloride
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospital
  4.1.2 Clinic
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 VAL-301 Production by Region
    6.1.1.2 GLPG-1492 Production by Region
    6.1.1.3 Solithromycin Production by Region
    6.1.1.4 Acorafloxacin Hydrochloride Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospital Production by Region
    6.1.2.2 Clinic Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 VAL-301 Demand by Region
    6.2.1.2 GLPG-1492 Demand by Region
    6.2.1.3 Solithromycin Demand by Region
    6.2.1.4 Acorafloxacin Hydrochloride Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospital Demand by Region
    6.2.2.2 Clinic Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Allergan Plc
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Galapagos NV
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Merck & Co Inc
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Syntiron LLC
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Valevia UK Ltd
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Industry Dynamics & Regulations List
Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Status by Type 2015-2018E, in USD Million
Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Status by Application 2015-2018E, in USD Million
Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Status by Application 2015-2018E, in Volume
Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market by Region 2015-2018E, in USD Million
Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Share by Region in 2018, in USD Million
Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market by Region 2015-2018E, in Volume
Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Share by Region in 2018, in Volume
Table VAL-301 Production Value by Region 2015-2018E, in USD Million
Table VAL-301 Production Volume by Region 2015-2018E, in Volume
Table GLPG-1492 Production Value by Region 2015-2018E, in USD Million
Table GLPG-1492 Production Volume by Region 2015-2018E, in Volume
Table Solithromycin Production Value by Region 2015-2018E, in USD Million
Table Solithromycin Production Volume by Region 2015-2018E, in Volume
Table Acorafloxacin Hydrochloride Production Value by Region 2015-2018E, in USD Million
Table Acorafloxacin Hydrochloride Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table VAL-301 Market Size by Region 2015-2018E, in USD Million
Table VAL-301 Market Size by Region 2015-2018E, in Volume
Table GLPG-1492 Market Size by Region 2015-2018E, in USD Million
Table GLPG-1492 Market Size by Region 2015-2018E, in Volume
Table Solithromycin Market Size by Region 2015-2018E, in USD Million
Table Solithromycin Market Size by Region 2015-2018E, in Volume
Table Acorafloxacin Hydrochloride Market Size by Region 2015-2018E, in USD Million
Table Acorafloxacin Hydrochloride Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalCommunity Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Forecast by Type 2019F-2025F, in USD Million
Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Forecast by Type 2019F-2025F, in Volume
Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast by Region 2019F-2025F, in USD Million
Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast by Region 2019F-2025F, in Volume
Table Allergan Plc Information
Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Cost, Margin of Allergan Plc
Table Galapagos NV Information
Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Cost, Margin of Galapagos NV
Table Merck & Co Inc Information
Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Cost, Margin of Merck & Co Inc
Table Syntiron LLC Information
Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Cost, Margin of Syntiron LLC
Table Valevia UK Ltd Information
Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Cost, Margin of Valevia UK Ltd
Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Volume by Company 2015-2017, in Volume
Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Picture
Figure Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Industry Chain Diagram
Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Revenue 2015-2018E, in USD Million
Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Volume 2015-2018E, in Volume
Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Status by Type 2015-2018E, in Volume
Figure North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in Volume
Figure South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size and Growth 2015-2018E, in Volume
Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Price Forecast 2019F-2025F
Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Gross Margin Forecast 2019F-2025F
Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Revenue by Company in 2018, in USD Million
Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Price by Company in 2018
Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Gross Margin by Company in 2018

More Publications

Need Help?

Ask a Question

Market Reports

All Categories